▶ 調査レポート

ヘレセプチンバイオシミラーのグローバル販売市場 2020年

• 英文タイトル:Global Hereceptin Biosimilar Sales Market Report 2020
• レポートコード:MRC2102QY6371
• 出版社/出版日: / 2021年1月
• レポート形態:英文、PDF、137ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥540,000 (USD4,000)▷ お問い合わせ
  Multi User¥810,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,080,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界のヘレセプチンバイオシミラー市場について種類別(錠剤、カプセル)、用途別(医薬品、医療、その他)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・ヘレセプチンバイオシミラー市場の概要
・世界の主要地域別ヘレセプチンバイオシミラー市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のヘレセプチンバイオシミラー市場規模2015-2026:種類別(錠剤、カプセル)
・世界のヘレセプチンバイオシミラー市場規模2015-2026:用途別(医薬品、医療、その他)
・ヘレセプチンバイオシミラーの米国市場規模2015-2020
・ヘレセプチンバイオシミラーのヨーロッパ市場規模2015-2020
・ヘレセプチンバイオシミラーの中国市場規模2015-2020
・ヘレセプチンバイオシミラーの日本市場規模2015-2020
・ヘレセプチンバイオシミラーの東南アジア市場規模2015-2020
・ヘレセプチンバイオシミラーのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・ヘレセプチンバイオシミラーの製造コスト分析
・販売チャネル、流通業者、顧客
・ヘレセプチンバイオシミラーの市場動向・機会・課題
・調査の結論

Market Analysis and Insights: Global Hereceptin Biosimilar Market
The global Hereceptin Biosimilar market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Hereceptin Biosimilar Scope and Market Size
The global Hereceptin Biosimilar market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hereceptin Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Hereceptin Biosimilar market is segmented into
Tablet
Capsule

Segment by Application, the Hereceptin Biosimilar market is segmented into
Pharmaceuticals
Healthcare
Others

The Hereceptin Biosimilar market is analysed and market size information is provided by regions (countries). Segment by Application, the Hereceptin Biosimilar market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Hereceptin Biosimilar Market Share Analysis
Hereceptin Biosimilar market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hereceptin Biosimilar business, the date to enter into the Hereceptin Biosimilar market, Hereceptin Biosimilar product introduction, recent developments, etc.

The major vendors covered:
Mylan N.V.
AryoGen Biopharma
Genor Biopharma
Celltrion Inc.
Amgen Inc.
Mabion S.A.
The Instituto Vital Brazil
F. Hoffmann-La Roche AG
Biocon
Gedeon Richter Plc

レポート目次

1 Hereceptin Biosimilar Market Overview
1.1 Hereceptin Biosimilar Product Scope
1.2 Hereceptin Biosimilar Segment by Type
1.2.1 Global Hereceptin Biosimilar Sales by Type (2020-2026)
1.2.2 Tablet
1.2.3 Capsule
1.3 Hereceptin Biosimilar Segment by Application
1.3.1 Global Hereceptin Biosimilar Sales Comparison by Application (2020-2026)
1.3.2 Pharmaceuticals
1.3.3 Healthcare
1.3.4 Others
1.4 Hereceptin Biosimilar Market Estimates and Forecasts (2015-2026)
1.4.1 Global Hereceptin Biosimilar Sales Growth Rate (2015-2026)
1.4.2 Global Hereceptin Biosimilar Revenue and Growth Rate (2015-2026)
1.4.3 Global Hereceptin Biosimilar Price Trends (2015-2026)

2 Hereceptin Biosimilar Estimate and Forecast by Region
2.1 Global Hereceptin Biosimilar Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Hereceptin Biosimilar Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Hereceptin Biosimilar Sales Market Share by Region (2015-2020)
2.2.2 Global Hereceptin Biosimilar Revenue Market Share by Region (2015-2020)
2.3 Global Hereceptin Biosimilar Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Hereceptin Biosimilar Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Hereceptin Biosimilar Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Hereceptin Biosimilar Estimates and Projections (2015-2026)
2.4.2 Europe Hereceptin Biosimilar Estimates and Projections (2015-2026)
2.4.3 China Hereceptin Biosimilar Estimates and Projections (2015-2026)
2.4.4 Japan Hereceptin Biosimilar Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Hereceptin Biosimilar Estimates and Projections (2015-2026)
2.4.6 India Hereceptin Biosimilar Estimates and Projections (2015-2026)
3 Global Hereceptin Biosimilar Competition Landscape by Players
3.1 Global Top Hereceptin Biosimilar Players by Sales (2015-2020)
3.2 Global Top Hereceptin Biosimilar Players by Revenue (2015-2020)
3.3 Global Hereceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereceptin Biosimilar as of 2019)
3.4 Global Hereceptin Biosimilar Average Price by Company (2015-2020)
3.5 Manufacturers Hereceptin Biosimilar Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Hereceptin Biosimilar Players (Opinion Leaders)
4 Global Hereceptin Biosimilar Market Size by Type
4.1 Global Hereceptin Biosimilar Historic Market Review by Type (2015-2020)
4.1.1 Global Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
4.1.2 Global Hereceptin Biosimilar Revenue Market Share by Type (2015-2020)
4.1.3 Global Hereceptin Biosimilar Price by Type (2015-2020)
4.2 Global Hereceptin Biosimilar Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Hereceptin Biosimilar Sales Forecast by Type (2021-2026)
4.2.2 Global Hereceptin Biosimilar Revenue Forecast by Type (2021-2026)
4.2.3 Global Hereceptin Biosimilar Price Forecast by Type (2021-2026)
5 Global Hereceptin Biosimilar Market Size by Application
5.1 Global Hereceptin Biosimilar Historic Market Review by Application (2015-2020)
5.1.1 Global Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
5.1.2 Global Hereceptin Biosimilar Revenue Market Share by Application (2015-2020)
5.1.3 Global Hereceptin Biosimilar Price by Application (2015-2020)
5.2 Global Hereceptin Biosimilar Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Hereceptin Biosimilar Sales Forecast by Application (2021-2026)
5.2.2 Global Hereceptin Biosimilar Revenue Forecast by Application (2021-2026)
5.2.3 Global Hereceptin Biosimilar Price Forecast by Application (2021-2026)

6 United States Hereceptin Biosimilar Market Facts & Figures
6.1 United States Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
6.2 United States Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
6.3 United States Hereceptin Biosimilar Sales Market Share by Application (2015-2020)

7 Europe Hereceptin Biosimilar Market Facts & Figures
7.1 Europe Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
7.2 Europe Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
7.3 Europe Hereceptin Biosimilar Sales Market Share by Application (2015-2020)

8 China Hereceptin Biosimilar Market Facts & Figures
8.1 China Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
8.2 China Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
8.3 China Hereceptin Biosimilar Sales Market Share by Application (2015-2020)

9 Japan Hereceptin Biosimilar Market Facts & Figures
9.1 Japan Hereceptin Biosimilar Sales Market Share by Company (3015-3030)
9.2 Japan Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
9.3 Japan Hereceptin Biosimilar Sales Market Share by Application (2015-2020)

10 Southeast Asia Hereceptin Biosimilar Market Facts & Figures
10.1 Southeast Asia Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Hereceptin Biosimilar Sales Market Share by Application (2015-2020)

11 India Hereceptin Biosimilar Market Facts & Figures
11.1 India Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
11.2 India Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
11.3 India Hereceptin Biosimilar Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Hereceptin Biosimilar Business
12.1 Mylan N.V.
12.1.1 Mylan N.V. Corporation Information
12.1.2 Mylan N.V. Business Overview
12.1.3 Mylan N.V. Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Mylan N.V. Hereceptin Biosimilar Products Offered
12.1.5 Mylan N.V. Recent Development
12.2 AryoGen Biopharma
12.2.1 AryoGen Biopharma Corporation Information
12.2.2 AryoGen Biopharma Business Overview
12.2.3 AryoGen Biopharma Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AryoGen Biopharma Hereceptin Biosimilar Products Offered
12.2.5 AryoGen Biopharma Recent Development
12.3 Genor Biopharma
12.3.1 Genor Biopharma Corporation Information
12.3.2 Genor Biopharma Business Overview
12.3.3 Genor Biopharma Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Genor Biopharma Hereceptin Biosimilar Products Offered
12.3.5 Genor Biopharma Recent Development
12.4 Celltrion Inc.
12.4.1 Celltrion Inc. Corporation Information
12.4.2 Celltrion Inc. Business Overview
12.4.3 Celltrion Inc. Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Celltrion Inc. Hereceptin Biosimilar Products Offered
12.4.5 Celltrion Inc. Recent Development
12.5 Amgen Inc.
12.5.1 Amgen Inc. Corporation Information
12.5.2 Amgen Inc. Business Overview
12.5.3 Amgen Inc. Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Amgen Inc. Hereceptin Biosimilar Products Offered
12.5.5 Amgen Inc. Recent Development
12.6 Mabion S.A.
12.6.1 Mabion S.A. Corporation Information
12.6.2 Mabion S.A. Business Overview
12.6.3 Mabion S.A. Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Mabion S.A. Hereceptin Biosimilar Products Offered
12.6.5 Mabion S.A. Recent Development
12.7 The Instituto Vital Brazil
12.7.1 The Instituto Vital Brazil Corporation Information
12.7.2 The Instituto Vital Brazil Business Overview
12.7.3 The Instituto Vital Brazil Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.7.4 The Instituto Vital Brazil Hereceptin Biosimilar Products Offered
12.7.5 The Instituto Vital Brazil Recent Development
12.8 F. Hoffmann-La Roche AG
12.8.1 F. Hoffmann-La Roche AG Corporation Information
12.8.2 F. Hoffmann-La Roche AG Business Overview
12.8.3 F. Hoffmann-La Roche AG Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.8.4 F. Hoffmann-La Roche AG Hereceptin Biosimilar Products Offered
12.8.5 F. Hoffmann-La Roche AG Recent Development
12.9 Biocon
12.9.1 Biocon Corporation Information
12.9.2 Biocon Business Overview
12.9.3 Biocon Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Biocon Hereceptin Biosimilar Products Offered
12.9.5 Biocon Recent Development
12.10 Gedeon Richter Plc
12.10.1 Gedeon Richter Plc Corporation Information
12.10.2 Gedeon Richter Plc Business Overview
12.10.3 Gedeon Richter Plc Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Gedeon Richter Plc Hereceptin Biosimilar Products Offered
12.10.5 Gedeon Richter Plc Recent Development

13 Hereceptin Biosimilar Manufacturing Cost Analysis
13.1 Hereceptin Biosimilar Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hereceptin Biosimilar
13.4 Hereceptin Biosimilar Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hereceptin Biosimilar Distributors List
14.3 Hereceptin Biosimilar Customers

15 Market Dynamics
15.1 Hereceptin Biosimilar Market Trends
15.2 Hereceptin Biosimilar Opportunities and Drivers
15.3 Hereceptin Biosimilar Market Challenges
15.4 Hereceptin Biosimilar Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Hereceptin Biosimilar Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Hereceptin Biosimilar Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Hereceptin Biosimilar Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Hereceptin Biosimilar Sales (MT) by Region (2015-2020)
Table 5. Global Hereceptin Biosimilar Sales Market Share by Region (2015-2020)
Table 6. Global Hereceptin Biosimilar Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Hereceptin Biosimilar Revenue Share by Region (2015-2020)
Table 8. Global Hereceptin Biosimilar Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Hereceptin Biosimilar Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Hereceptin Biosimilar Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Hereceptin Biosimilar Revenue Share Forecast by Region (2021-2026)
Table 12. Global Hereceptin Biosimilar (MT) of Key Companies (2015-2020)
Table 13. Global Hereceptin Biosimilar Sales Share by Company (2015-2020)
Table 14. Global Hereceptin Biosimilar Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Hereceptin Biosimilar Revenue Share by Company (2015-2020)
Table 16. Global Hereceptin Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereceptin Biosimilar as of 2019)
Table 17. Global Hereceptin Biosimilar Average Price (K USD/Kg) of Key Company (2015-2020)
Table 18. Manufacturers Hereceptin Biosimilar Manufacturing Sites and Area Served
Table 19. Manufacturers Hereceptin Biosimilar Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Hereceptin Biosimilar Players
Table 22. Global Hereceptin Biosimilar Sales (MT) by Type (2015-2020)
Table 23. Global Hereceptin Biosimilar Sales Share by Type (2015-2020)
Table 24. Global Hereceptin Biosimilar Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Hereceptin Biosimilar Price (MT) by Type (2015-2020)
Table 26. Global Hereceptin Biosimilar Sales Share by Type (2021-2026)
Table 27. Global Hereceptin Biosimilar Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Hereceptin Biosimilar Revenue Share by Type (2021-2026)
Table 29. Global Hereceptin Biosimilar Price (MT) by Type (2021-2026)
Table 30. Global Hereceptin Biosimilar Sales (MT) by Application (2015-2020)
Table 31. Global Hereceptin Biosimilar Sales Share by Application (2015-2020)
Table 32. Global Hereceptin Biosimilar Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Hereceptin Biosimilar Price (MT) by Application (2015-2020)
Table 34. Global Hereceptin Biosimilar Sales (MT) by Application (2021-2026)
Table 35. Global Hereceptin Biosimilar Sales Share by Application (2021-2026)
Table 36. Global Hereceptin Biosimilar Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Hereceptin Biosimilar Revenue Share by Application (2021-2026)
Table 38. Global Hereceptin Biosimilar Price (MT) by Application (2021-2026)
Table 39. United States Hereceptin Biosimilar Sales (MT) by Company (2015-2020)
Table 40. United States Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
Table 41. United States Hereceptin Biosimilar Sales (MT) by Type (2015-2020)
Table 42. United States Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 43. United States Hereceptin Biosimilar Sales (MT) by Application (2015-2020)
Table 44. United States Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 45. Europe Hereceptin Biosimilar Sales (MT) by Company (2015-2020)
Table 46. Europe Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
Table 47. Europe Hereceptin Biosimilar Sales (MT) by Type (2015-2020)
Table 48. Europe Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 49. Europe Hereceptin Biosimilar Sales (MT) by Application (2015-2020)
Table 50. Europe Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 51. China Hereceptin Biosimilar Sales (MT) by Company (2015-2020)
Table 52. China Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
Table 53. China Hereceptin Biosimilar Sales (MT) by Type (2015-2020)
Table 54. China Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 55. China Hereceptin Biosimilar Sales (MT) by Application (2015-2020)
Table 56. China Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 57. Japan Hereceptin Biosimilar Sales (MT) by Company (2015-2020)
Table 58. Japan Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
Table 59. Japan Hereceptin Biosimilar Sales (MT) by Type (2015-2020)
Table 60. Japan Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 61. Japan Hereceptin Biosimilar Sales (MT) by Application (2015-2020)
Table 62. Japan Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Hereceptin Biosimilar Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Hereceptin Biosimilar Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Hereceptin Biosimilar Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 69. India Hereceptin Biosimilar Sales (MT) by Company (2015-2020)
Table 70. India Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
Table 71. India Hereceptin Biosimilar Sales (MT) by Type (2015-2020)
Table 72. India Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 73. India Hereceptin Biosimilar Sales (MT) by Application (2015-2020)
Table 74. India Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 75. Mylan N.V. Corporation Information
Table 76. Mylan N.V. Description and Business Overview
Table 77. Mylan N.V. Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 78. Mylan N.V. Hereceptin Biosimilar Product
Table 79. Mylan N.V. Recent Development
Table 80. AryoGen Biopharma Corporation Information
Table 81. AryoGen Biopharma Description and Business Overview
Table 82. AryoGen Biopharma Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 83. AryoGen Biopharma Hereceptin Biosimilar Product
Table 84. AryoGen Biopharma Recent Development
Table 85. Genor Biopharma Corporation Information
Table 86. Genor Biopharma Description and Business Overview
Table 87. Genor Biopharma Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 88. Genor Biopharma Hereceptin Biosimilar Product
Table 89. Genor Biopharma Recent Development
Table 90. Celltrion Inc. Corporation Information
Table 91. Celltrion Inc. Description and Business Overview
Table 92. Celltrion Inc. Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 93. Celltrion Inc. Hereceptin Biosimilar Product
Table 94. Celltrion Inc. Recent Development
Table 95. Amgen Inc. Corporation Information
Table 96. Amgen Inc. Description and Business Overview
Table 97. Amgen Inc. Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 98. Amgen Inc. Hereceptin Biosimilar Product
Table 99. Amgen Inc. Recent Development
Table 100. Mabion S.A. Corporation Information
Table 101. Mabion S.A. Description and Business Overview
Table 102. Mabion S.A. Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 103. Mabion S.A. Hereceptin Biosimilar Product
Table 104. Mabion S.A. Recent Development
Table 105. The Instituto Vital Brazil Corporation Information
Table 106. The Instituto Vital Brazil Description and Business Overview
Table 107. The Instituto Vital Brazil Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 108. The Instituto Vital Brazil Hereceptin Biosimilar Product
Table 109. The Instituto Vital Brazil Recent Development
Table 110. F. Hoffmann-La Roche AG Corporation Information
Table 111. F. Hoffmann-La Roche AG Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 112. F. Hoffmann-La Roche AG Description and Business Overview
Table 113. F. Hoffmann-La Roche AG Hereceptin Biosimilar Product
Table 114. F. Hoffmann-La Roche AG Recent Development
Table 115. Biocon Corporation Information
Table 116. Biocon Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 117. Biocon Description and Business Overview
Table 118. Biocon Hereceptin Biosimilar Product
Table 119. Biocon Recent Development
Table 120. Gedeon Richter Plc Corporation Information
Table 121. Gedeon Richter Plc Description and Business Overview
Table 122. Gedeon Richter Plc Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 123. Gedeon Richter Plc Hereceptin Biosimilar Product
Table 124. Gedeon Richter Plc Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Hereceptin Biosimilar Distributors List
Table 128. Hereceptin Biosimilar Customers List
Table 129. Hereceptin Biosimilar Market Key Trends
Table 130. Hereceptin Biosimilar Key Opportunities and Drivers
Table 131. Hereceptin Biosimilar Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Hereceptin Biosimilar Product Picture
Figure 2. Global Hereceptin Biosimilar Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hereceptin Biosimilar Market Share by Application in 2020 & 2026
Figure 6. Pharmaceuticals Examples
Figure 7. Healthcare Examples
Figure 8. Others Examples
Figure 9. Global Hereceptin Biosimilar Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Hereceptin Biosimilar Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Hereceptin Biosimilar Price Trends Growth Rate (2015-2026) (K USD/Kg)
Figure 12. Global Hereceptin Biosimilar Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Hereceptin Biosimilar Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Hereceptin Biosimilar Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Hereceptin Biosimilar Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Hereceptin Biosimilar Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Hereceptin Biosimilar Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Hereceptin Biosimilar Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Hereceptin Biosimilar Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Hereceptin Biosimilar Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Hereceptin Biosimilar Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Hereceptin Biosimilar Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Hereceptin Biosimilar Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Hereceptin Biosimilar Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Hereceptin Biosimilar Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Hereceptin Biosimilar Players Market Share by Revenue in Hereceptin Biosimilar 2015 & 2019
Figure 27. Hereceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Hereceptin Biosimilar Revenue Share by Type (2015-2020)
Figure 29. Global Hereceptin Biosimilar Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Hereceptin Biosimilar Revenue Share by Application (2015-2020)
Figure 31. Global Hereceptin Biosimilar Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Hereceptin Biosimilar Sales Market Share by Type in 2019
Figure 33. United States Hereceptin Biosimilar Sales Market Share by Type in 2019
Figure 34. Europe Hereceptin Biosimilar Sales Market Share by Company in 2019
Figure 35. Europe Hereceptin Biosimilar Sales Market Share by Type in 2019
Figure 36. Europe Hereceptin Biosimilar Sales Market Share by Application in 2019
Figure 37. China Hereceptin Biosimilar Sales Market Share by Company in 2019
Figure 38. China Hereceptin Biosimilar Sales Market Share by Type in 2019
Figure 39. China Hereceptin Biosimilar Sales Market Share by Application in 2019
Figure 40. Japan Hereceptin Biosimilar Sales Market Share by Company in 2019
Figure 41. Japan Hereceptin Biosimilar Sales Market Share by Type in 2019
Figure 42. Japan Hereceptin Biosimilar Sales Market Share by Application in 2019
Figure 43. Southeast Asia Hereceptin Biosimilar Sales Market Share by Company in 2019
Figure 44. Southeast Asia Hereceptin Biosimilar Sales Market Share by Type in 2019
Figure 45. Southeast Asia Hereceptin Biosimilar Sales Market Share by Application in 2019
Figure 46. India Hereceptin Biosimilar Sales Market Share by Company in 2019
Figure 47. India Hereceptin Biosimilar Sales Market Share by Type in 2019
Figure 48. India Hereceptin Biosimilar Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Hereceptin Biosimilar
Figure 51. Manufacturing Process Analysis of Hereceptin Biosimilar
Figure 52. Hereceptin Biosimilar Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed



• 英文レポート名:Global Hereceptin Biosimilar Sales Market Report 2020
• 日本語訳:ヘレセプチンバイオシミラーのグローバル販売市場 2020年
• レポートコード:MRC2102QY6371お問い合わせ(見積依頼・ご注文・質問)